Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04597671
Title Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) (NVALT28)
Acronym NVALT28
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Association NVALT Studies
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
ZGT RECRUITING Almelo Netherlands Details
AmsterdamUMC - location VUmc ACTIVE_NOT_RECRUITING Amsterdam Netherlands Details
Radiotherapie Groep ACTIVE_NOT_RECRUITING Arnhem Netherlands Details
Rijnstate RECRUITING Arnhem Netherlands Details
Gelderse Vallei RECRUITING Ede Netherlands Details
Catharina Ziekenhuis RECRUITING Eindhoven Netherlands Details
UMCG RECRUITING Groningen Netherlands Details
Maastro RECRUITING Maastricht 5912 BL Netherlands Details
Canisius Wilhemina Ziekenhuis RECRUITING Nijmegen Netherlands Details
Radboud UMC RECRUITING Nijmegen Netherlands Details
ZorgSaam Ziekenhuis RECRUITING Terneuzen Netherlands Details
Maxima Medisch Centrum RECRUITING Veldhoven Netherlands Details
ZRTI ACTIVE_NOT_RECRUITING Vlissingen Netherlands Details
Zaans Medisch Centrum RECRUITING Zaandam Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field